High Follistatin Predicts Poor Cardiometabolic Outcomes

Elevated plasma levels of the liver protein follistatin may predict incident chronic kidney disease and other adverse outcomes, independent of diabetes, based on 23-year follow-up of a Swedish cohort.
First Look

source https://www.medscape.com/viewarticle/991683?src=rss